It is indicated for routine prophylaxis to help prevent or reduce the frequency of bleeding episodes in adolescents, adults, and elderly individuals with hemophilia A (without factor VIII inhibitors) or hemophilia B (without factor IX inhibitors) [22]. This evidence concerns the gene F9 and hemophilia A.